Meet the RWE innovators using AI and analytics to drive impact.
Real-world evidence (RWE) is reshaping how life sciences companies make decisions—fueling clinical trials, accelerating market access, and improving patient outcomes. But in a fragmented vendor landscape, who’s setting the pace?
The Frost Radar™: Life Sciences Real-World Evidence Solutions, 2025 identifies the top 16 companies leading with innovation and growth. With over 120 vendors in the market, Frost & Sullivan’s expert analysis evaluates performance across data integration, real-time analytics, scalability, and patient-centric innovation.
Discover key insights:
-
How OM1’s AI is reshaping chronic disease management
-
Why Optum leads in regulatory-grade data integration
-
How Verana Health uses real-time population data to optimize trials
-
The role of generative AI (GenAI) and decentralized trials in the next wave of RWE
Stay ahead of the curve—partner with visionaries.
Download Now
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.
*$1,000 honorarium is subject to eligibility
